Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial

BACKGROUND: Radiotherapy, preferably combined with chemotherapy, is the treatment standard for locally advanced, unresectable non-small cell lung cancer (NSCLC). The tumor response to different therapy protocols is variable, with hypoxia known to be a major factor that negatively influences treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Askoxylakis, Vasileios, Dinkel, Julien, Eichinger, Monika, Stieltjes, Bram, Sommer, Gregor, Strauss, Ludwig G, Dimitrakopoulou-Strauss, Antonia, Kopp-Schneider, Annette, Haberkorn, Uwe, Huber, Peter E, Bischof, Marc, Debus, Jürgen, Thieke, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503648/
https://www.ncbi.nlm.nih.gov/pubmed/22974533
http://dx.doi.org/10.1186/1748-717X-7-157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503648/
https://www.ncbi.nlm.nih.gov/pubmed/22974533
http://dx.doi.org/10.1186/1748-717X-7-157

Ejemplares similares